Tirofiban indications and usage: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
ShiSheng (talk | contribs)
nocaptcha
8,707 edits
Created page with "__NOTOC__ {{Tirofiban}} {{CMG}}; {{AE}} {{SS}} ==Indications and Usage== AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of ..."
 
GeraldChi (talk | contribs)
Bureaucrats, bureaucrats, nocaptcha, Administrators
8,887 edits
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Tirofiban#Adult Indications and Dosage]]
{{Tirofiban}}
{{CMG}}; {{AE}} {{SS}}
 
==Indications and Usage==
 
AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, [[myocardial infarction]], or[[ refractory ischemia]]/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = AGGRASTAT (TIROFIBAN) INJECTION, SOLUTION [MEDICURE INTERNATIONAL INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe0ced75-ccbf-4d2e-bd0d-b57e60ab913f | publisher =  | date =  | accessdate = 6 February 2014 }}</ref>
 
 
==References==
 
{{Reflist|2}}
 
{{Antithrombotics}}
 
[[Category:Antiplatelet drugs]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 02:53, 22 July 2014

Redirect to:

Retrieved from "https://www.wikidoc.org/index.php?title=Tirofiban_indications_and_usage&oldid=998637"